Reversible Cerebral Vasoconstriction Syndrome with Intracerebral Hemorrhage in a Thalassemic Child—An Extremely Rare Complication

Abstract

A 6-year-old known thalassemic boy presented with a posttransfusional thunderclap headache. A computed tomography scan showed left occipital lobar bleed and magnetic resonance angiography showed diffuse cerebral vasoconstriction, which resolved after 3 months, suggesting reversible cerebral vasoconstriction syndrome. He was treated with oral nimodipine for 3 months and had an excellent recovery without sequelae. To the best of the authors' knowledge, the index case is the first reported case of reversible cerebral vasoconstriction syndrome in a thalassemic child.

Keywords

thalassemia - thunderclap - reversible - vasoconstriction

Publication History

Received: 22 September 2022

Accepted: 28 December 2022

Article published online:
06 February 2023

• References

• 1 Coffino SW, Fryer RH. Reversible cerebral vasoconstriction syndrome in pediatrics: a case series and review. J Child Neurol 2017; 32 (07) 614-623
• 2 Yoshioka S, Takano T, Ryujin F, Takeuchi Y. A pediatric case of reversible cerebral vasoconstriction syndrome with cortical subarachnoid hemorrhage. Brain Dev 2012; 34 (09) 796-798
• 3 Maldonado-Soto AR, Fryer RH. Reversible cerebral vasoconstriction syndrome in children: an update. Semin Pediatr Neurol 2021; 40: 100936
• 4 Desai N, Bhadeka R, Shah N, Udani V. Pediatric reversible cerebral vasoconstriction syndrome: two unique cases with a review of all reported children. J Pediatr Neurol 2021; 20 (01) 41-47
• 5 Sadeghizadeh A, Pourmoghaddas Z, Zandifar A. et al. Reversible cerebral vasoconstriction syndrome and multisystem inflammatory syndrome in children with COVID-19. Pediatr Neurol 2022; 129: 1-6
• 6 Simon D, Peraino J, Thusang K, Khalil S. Pediatric RCVS in newly diagnosed all treated with intra-arterial nicardipine. J Pediatr Neurol Neurosci 2020; 4 (01) 76-78
• 7 Singhal AB, Hajj-Ali RA, Topcuoglu MA. et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011; 68 (08) 1005-1012
• 8 Probert R, Saunders DE, Ganesan V. Reversible cerebral vasoconstriction syndrome: rare or underrecognized in children?. Dev Med Child Neurol 2013; 55 (04) 385-389
• 9 Durrleman C, Naggara O, Grevent D. et al. Reversible cerebral vasoconstriction syndrome in paediatric patients with systemic lupus erythematosus: implications for management. Dev Med Child Neurol 2019; 61 (06) 725-729
• 10 Regling K, Pomerantz D, Narayanan S. et al. Reversible cerebral vasoconstriction syndrome and sickle cell disease: a case report. J Pediatr Hematol Oncol 2021; 43 (01) e95-e98
• 11 Liang H, Xu Z, Zheng Z, Lou H, Yue W. Reversible cerebral vasoconstriction syndrome following red blood cells transfusion: a case series of 7 patients. Orphanet J Rare Dis 2015; 10: 47
• 12 Agarwal R, Davis C, Altinok D, Serajee FJ. Posterior reversible encephalopathy and cerebral vasoconstriction in a patient with hemolytic uremic syndrome. Pediatr Neurol 2014; 50 (05) 518-521
• 13 Jeanneret V, Jillella DV, Rangaraju S. et al. PRES and RCVS: two distinct entities or a spectrum of the same disease?. J Stroke Cerebrovasc Dis 2022; 31 (06) 106472
• 14 Singhal AB. Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome as syndromes of cerebrovascular dysregulation. Continuum (Minneap Minn) 2021; 27 (05) 1301-1320
• 15 Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology (Am Soc Hematol Educ Program) 2008; 1: 177-185
• 16 Taylor VI JG, Nolan VG, Mendelsohn L, Kato GJ, Gladwin MT, Steinberg MH. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008; 3 (05) e2095
• 17 Shimoda M, Oda S, Shigematsu H. et al. Clinical significance of centripetal propagation of vasoconstriction in patients with reversible cerebral vasoconstriction syndrome: a retrospective case-control study. Cephalalgia 2018; 38 (12) 1864-1875